CATL Files Initial Prospectus for Hong Kong Listing
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 06 2025
0mins
Source: WSJ
Company Announcement: Contemporary Amperex Technology, a leading Chinese battery manufacturer, has submitted a preliminary prospectus for a secondary listing on the Hong Kong Exchange to capitalize on the growing electric vehicle market.
Advisers Involved: The listing process is supported by major financial institutions including BofA Securities, Goldman Sachs, J.P. Morgan, and CICC, as stated in the company's prospectus.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GS
Wall Street analysts forecast GS stock price to rise
12 Analyst Rating
5 Buy
7 Hold
0 Sell
Moderate Buy
Current: 835.460
Low
604.00
Averages
951.45
High
1100
Current: 835.460
Low
604.00
Averages
951.45
High
1100
About GS
The Goldman Sachs Group, Inc. is a global financial institution that delivers a range of financial services to a large and diversified client base that includes corporations, financial institutions, governments and individuals. Its segments include Global Banking & Markets, Asset & Wealth Management and Platform Solutions. The Global Banking & Markets segment offers a range of services, including financing, advisory services, risk distribution, and hedging for its institutional and corporate clients. It facilitates client transactions and makes markets in fixed income, equity, currency and commodity products. The Asset & Wealth Management segment manages assets and offers investment products across all asset classes to a diverse set of clients. It also provides investing and wealth advisory solutions. The Platform Solutions segment includes consumer platforms, such as partnerships offering credit cards and point-of-sale financing, and transaction banking and other platform businesses.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Goldman Sachs Completes Majority Investment in Mace Consult
- Majority Investment Completed: Goldman Sachs Alternatives has successfully completed its majority investment in Mace Consult, marking the company's independence from Mace Group and establishing it as a leading provider of project management services globally, which is expected to drive growth in infrastructure and capital projects.
- Global Expansion Strategy: Mace Consult plans to leverage Goldman Sachs' capital support to accelerate its expansion in the North American market and invest in digital tools to enhance predictability and automation in project delivery, thereby improving client satisfaction and competitive positioning.
- Significant Revenue Growth: Mace Consult generated nearly $1 billion in revenue in 2025, indicating strong performance in target markets such as infrastructure, clean energy, and digital connectivity, with new investments expected to further propel growth in these areas.
- Industry Leadership Position: Mace Consult collaborates with Fortune 500 clients on several iconic infrastructure projects, and the new independent structure will enable it to better manage client delivery, elevate industry standards, and enhance its market leadership.
See More
Goldman Sachs Lists Must-Buy Stocks Amid Market Fears
- Goldman Sachs Recommendations: Goldman Sachs recently highlighted stocks including Nvidia, Ross Stores, Viking Holdings, Once Upon a Farm, and Dutch Bros as must-buys amid rising market fears, reflecting strong confidence in these companies.
- Dutch Bros. Growth Potential: Analyst Christine Cho upgraded Dutch Bros. from neutral to buy, noting its robust growth potential in the U.S. restaurant sector, particularly driven by solid same-store sales growth and strong unit economics supporting mid-teens store growth.
- Once Upon a Farm Brand Strength: Analyst Leah Jordan initiated coverage on Once Upon a Farm with a buy rating, emphasizing its strong brand power and defensible market position, while the company is well-positioned within the
See More
Goldman Sachs Analysts Warn of Market Risks
- Market Risk Warning: Goldman Sachs strategist Peter Oppenheimer highlights that current equity market risk premia have fallen to levels not seen since the lead-up to the 2008 financial crisis, indicating a need for caution despite improved market sentiment.
- AIG Financial Performance: American International Group (AIG) reported net premiums of $23.9 billion in 2024 and $23.8 billion in 2025, with a 48% year-over-year increase in general insurance underwriting income in Q4 2025, showcasing strong earnings growth potential.
- AIG Shareholder Returns: AIG returned $6.8 billion to shareholders over the past year, with $5.8 billion in share repurchases and $1 billion in dividends, demonstrating the company's capital management flexibility and commitment to shareholder value.
- Alcon Growth Outlook: Alcon achieved $2.7 billion in sales in Q4 2025, a 9% year-over-year increase, slightly below estimates, yet analysts remain optimistic about future growth, projecting a 27% increase in share price by 2027.
See More
NuScale Power Stock Plummets 33% Amid Analyst Downgrades and Lawsuits
- Significant Stock Decline: NuScale Power's stock has plummeted 33% over the past five weeks, with a 9% drop this week alone, reflecting a severe erosion of investor confidence and a pessimistic outlook on its future prospects.
- Analyst Downgrades: Several analysts have slashed their price targets for NuScale, with Citigroup reducing its target from $18.50 to $11.50 and Royal Bank of Canada cutting from $21 to $14, indicating growing concerns over the company's profitability and market position.
- Deteriorating Financials: On February 26, NuScale reported a 15% drop in projected 2025 revenue and a staggering 700% increase in general and administrative expenses, resulting in a net loss of $2.017 per share, significantly worse than the $1.47 loss in 2024, highlighting the financial strain the company is under.
- Legal Action Risks: A wave of class action lawsuits has been filed against NuScale, alleging misrepresentation of ENTRA1 Energy's capabilities, which could lead to milestone payments exceeding $300 million, further exacerbating market anxiety and uncertainty regarding the company's future cash flows.
See More
Middle East Tensions Weigh on Stock Market
- Market Reaction: The S&P 500 and Nasdaq both fell about 1% on Friday due to escalating tensions in the Middle East, reflecting increased investor uncertainty, particularly after President Trump stated there would be no deal with Iran.
- Rising Oil Prices: Oil prices reached their highest levels since April 2024, causing U.S. gas prices to rise, which benefits Costco as its reputation for low gas prices attracts more customers, leading to a 1% increase in its stock price on Friday.
- Financial Sector Pressure: Financial stocks continue to face pressure as a spike in private credit redemptions weighs on sentiment, with shares of Goldman Sachs, Capital One, and Wells Fargo declining, while BlackRock's stock dropped nearly 6% after it limited withdrawals from a private credit fund, raising concerns about financial health.
- Investment Strategy: During Friday's meeting, Jim Cramer highlighted that despite the market's downturn, there are still buying opportunities, particularly favoring Goldman Sachs and Cardinal Health, the latter of which saw its fourth purchase this week.
See More
Jim Cramer's Trust Increases Stake in Cardinal Health
- Share Acquisition: Jim Cramer's Charitable Trust purchased 50 shares of Cardinal Health at approximately $217.84, increasing its total holdings to 400 shares and raising its weighting from 2% to 2.25%, demonstrating ongoing confidence in the company.
- Market Performance Insight: Despite a broader market downturn, Cardinal Health's shares have risen, reflecting market trust in its resilience against rising oil prices and geopolitical tensions, indicating strong fundamentals.
- Investment Strategy: Cramer emphasizes a gradual accumulation strategy to lower the average cost basis, avoiding the risks associated with large one-time purchases, a tactic that proves crucial amid current market volatility.
- Financial Sector Dynamics: The financial sector is the worst performer, impacted by rising oil prices and weak job data; although Goldman Sachs offers a 2% dividend yield, market volatility may hinder its anticipated M&A and IPO activities.
See More
Goldman Sachs Completes Majority Investment in Mace Consult
- Majority Investment Completed: Goldman Sachs Alternatives has successfully completed its majority investment in Mace Consult, marking the company's independence from Mace Group and establishing it as a leading provider of project management services globally, which is expected to drive growth in infrastructure and capital projects.
- Global Expansion Strategy: Mace Consult plans to leverage Goldman Sachs' capital support to accelerate its expansion in the North American market and invest in digital tools to enhance predictability and automation in project delivery, thereby improving client satisfaction and competitive positioning.
- Significant Revenue Growth: Mace Consult generated nearly $1 billion in revenue in 2025, indicating strong performance in target markets such as infrastructure, clean energy, and digital connectivity, with new investments expected to further propel growth in these areas.
- Industry Leadership Position: Mace Consult collaborates with Fortune 500 clients on several iconic infrastructure projects, and the new independent structure will enable it to better manage client delivery, elevate industry standards, and enhance its market leadership.
See More
Goldman Sachs Lists Must-Buy Stocks Amid Market Fears
- Goldman Sachs Recommendations: Goldman Sachs recently highlighted stocks including Nvidia, Ross Stores, Viking Holdings, Once Upon a Farm, and Dutch Bros as must-buys amid rising market fears, reflecting strong confidence in these companies.
- Dutch Bros. Growth Potential: Analyst Christine Cho upgraded Dutch Bros. from neutral to buy, noting its robust growth potential in the U.S. restaurant sector, particularly driven by solid same-store sales growth and strong unit economics supporting mid-teens store growth.
- Once Upon a Farm Brand Strength: Analyst Leah Jordan initiated coverage on Once Upon a Farm with a buy rating, emphasizing its strong brand power and defensible market position, while the company is well-positioned within the
See More
Goldman Sachs Analysts Warn of Market Risks
- Market Risk Warning: Goldman Sachs strategist Peter Oppenheimer highlights that current equity market risk premia have fallen to levels not seen since the lead-up to the 2008 financial crisis, indicating a need for caution despite improved market sentiment.
- AIG Financial Performance: American International Group (AIG) reported net premiums of $23.9 billion in 2024 and $23.8 billion in 2025, with a 48% year-over-year increase in general insurance underwriting income in Q4 2025, showcasing strong earnings growth potential.
- AIG Shareholder Returns: AIG returned $6.8 billion to shareholders over the past year, with $5.8 billion in share repurchases and $1 billion in dividends, demonstrating the company's capital management flexibility and commitment to shareholder value.
- Alcon Growth Outlook: Alcon achieved $2.7 billion in sales in Q4 2025, a 9% year-over-year increase, slightly below estimates, yet analysts remain optimistic about future growth, projecting a 27% increase in share price by 2027.
See More
NuScale Power Stock Plummets 33% Amid Analyst Downgrades and Lawsuits
- Significant Stock Decline: NuScale Power's stock has plummeted 33% over the past five weeks, with a 9% drop this week alone, reflecting a severe erosion of investor confidence and a pessimistic outlook on its future prospects.
- Analyst Downgrades: Several analysts have slashed their price targets for NuScale, with Citigroup reducing its target from $18.50 to $11.50 and Royal Bank of Canada cutting from $21 to $14, indicating growing concerns over the company's profitability and market position.
- Deteriorating Financials: On February 26, NuScale reported a 15% drop in projected 2025 revenue and a staggering 700% increase in general and administrative expenses, resulting in a net loss of $2.017 per share, significantly worse than the $1.47 loss in 2024, highlighting the financial strain the company is under.
- Legal Action Risks: A wave of class action lawsuits has been filed against NuScale, alleging misrepresentation of ENTRA1 Energy's capabilities, which could lead to milestone payments exceeding $300 million, further exacerbating market anxiety and uncertainty regarding the company's future cash flows.
See More
Middle East Tensions Weigh on Stock Market
- Market Reaction: The S&P 500 and Nasdaq both fell about 1% on Friday due to escalating tensions in the Middle East, reflecting increased investor uncertainty, particularly after President Trump stated there would be no deal with Iran.
- Rising Oil Prices: Oil prices reached their highest levels since April 2024, causing U.S. gas prices to rise, which benefits Costco as its reputation for low gas prices attracts more customers, leading to a 1% increase in its stock price on Friday.
- Financial Sector Pressure: Financial stocks continue to face pressure as a spike in private credit redemptions weighs on sentiment, with shares of Goldman Sachs, Capital One, and Wells Fargo declining, while BlackRock's stock dropped nearly 6% after it limited withdrawals from a private credit fund, raising concerns about financial health.
- Investment Strategy: During Friday's meeting, Jim Cramer highlighted that despite the market's downturn, there are still buying opportunities, particularly favoring Goldman Sachs and Cardinal Health, the latter of which saw its fourth purchase this week.
See More
Jim Cramer's Trust Increases Stake in Cardinal Health
- Share Acquisition: Jim Cramer's Charitable Trust purchased 50 shares of Cardinal Health at approximately $217.84, increasing its total holdings to 400 shares and raising its weighting from 2% to 2.25%, demonstrating ongoing confidence in the company.
- Market Performance Insight: Despite a broader market downturn, Cardinal Health's shares have risen, reflecting market trust in its resilience against rising oil prices and geopolitical tensions, indicating strong fundamentals.
- Investment Strategy: Cramer emphasizes a gradual accumulation strategy to lower the average cost basis, avoiding the risks associated with large one-time purchases, a tactic that proves crucial amid current market volatility.
- Financial Sector Dynamics: The financial sector is the worst performer, impacted by rising oil prices and weak job data; although Goldman Sachs offers a 2% dividend yield, market volatility may hinder its anticipated M&A and IPO activities.
See More
